CROWLEY DEBORAH E – Trademark Portfolio
Entity Type: 01
CROWLEY DEBORAH E holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. The portfolio also extends into Class 25 (Clothing) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FLEXEFFECT, FACIALBUILDING, and SECURE OUR BORDER. The owner is based in EUREKA, CA.
1604 H ST
EUREKA, CA 95501
Showing of trademarks Trademarks
Trademark Classifications
CROWLEY DEBORAH E's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does CROWLEY DEBORAH E have?
CROWLEY DEBORAH E has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned, 1 cancelled.
What trademark classes does CROWLEY DEBORAH E file in?
CROWLEY DEBORAH E files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 25 (Clothing), Class 44 (Medical Services), Class 16 (Paper Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are CROWLEY DEBORAH E's most well-known trademarks?
CROWLEY DEBORAH E's registered trademark portfolio includes well-known marks such as FLEXEFFECT, FACIALBUILDING, and SECURE OUR BORDER. These are among 3 currently registered trademarks in the portfolio.
What is CROWLEY DEBORAH E's trademark registration success rate?
CROWLEY DEBORAH E has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.